Compare BIO & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | BSAC |
|---|---|---|
| Founded | 1952 | 1977 |
| Country | United States | Chile |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Commercial Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 16.0B |
| IPO Year | N/A | 2002 |
| Metric | BIO | BSAC |
|---|---|---|
| Price | $262.80 | $30.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $358.50 | $29.50 |
| AVG Volume (30 Days) | 302.3K | ★ 337.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.24% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.51 | $36.86 |
| Revenue Next Year | $3.17 | $7.32 |
| P/E Ratio | ★ $9.72 | $14.40 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $20.77 |
| 52 Week High | $343.12 | $37.72 |
| Indicator | BIO | BSAC |
|---|---|---|
| Relative Strength Index (RSI) | 36.10 | 34.67 |
| Support Level | $239.33 | $29.41 |
| Resistance Level | $264.68 | $30.77 |
| Average True Range (ATR) | 7.79 | 0.95 |
| MACD | -0.22 | -0.35 |
| Stochastic Oscillator | 12.17 | 9.35 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.